Status: Recruiting
Azacytidine Plus CAOLD Regimen in Relapsed/Refractory Peripheral T-Cell Lymphomas
This is a multicenter prospective single arm phase II study. The purpose of this study is to evaluate the safety and efficiency of azacytidine combined with CAOLD Regimen in the treatment of relapsed/refractory peripheral t-cell lymphomas.
Participants needed: 52
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Navy General Hospital, BeijingUpdated: Oct 29, 2024Locations: 1
Eligibility criteria
Pathologically confirmed angioimmunoblastic T-cell lymphoma according World Heal... [+8]
Active or uncontrolled infections requiring systemic treatment within 14 days be... [+2]